Enpro (NPO) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
5 May, 2026Strategic evolution and value creation
Transitioned from resolving legacy liabilities (2002–2018) to portfolio optimization (2019–2024) and now focuses on accelerating profitable growth with premium industrial technology and high EBITDA margins above 25%.
Recent acquisitions (Overlook Industries and Alpha Measurement Solutions) expand capabilities in biopharma and liquid analytical sensors, strengthening the Sealing Technologies segment.
Financial performance and guidance
LTM revenue as of March 31, 2026, was $1.2B with adjusted EBITDA of $286M (24.4% margin); market cap stands at $6.0B.
2026 guidance increased: revenue growth expected at 10–14%, adjusted EBITDA at $315M–$330M, and adjusted diluted EPS at $8.85–$9.50.
Free cash flow for Q1 2026 was $26.5M, up from $11.6M in the prior year; quarterly dividend increased for the 11th consecutive year.
Segment highlights
Sealing Technologies generated $199M in Q1 2026 sales with a 32.5% adjusted segment EBITDA margin, driven by strong aftermarket presence and proprietary solutions.
Advanced Surface Technologies posted $104M in Q1 2026 sales with a 23.3% margin, focusing on semiconductor and industrial markets with high barriers to entry.
Latest events from Enpro
- Sales up 17.6% and 2026 guidance raised as semiconductor and industrial demand accelerate.NPO
Q2 2026 - Raised 2026 guidance and premium margins reflect strong growth and portfolio expansion.NPO
Oppenheimer 21st Annual Industrial Growth Virtual Conference - Raised 2026 guidance after double-digit sales and EBITDA growth, led by semiconductor demand.NPO
Q1 2026 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG progress.NPO
Proxy filing - Strong 2025 results and 2026 growth outlook driven by high-margin tech focus and strategic acquisitions.NPO
Investor presentation - 2025 saw 9% sales growth and margin gains, with 2026 guidance projecting further increases.NPO
Q4 2025 - Adjusted EBITDA rose 14% to $74.0M as Sealing Technologies offset semiconductor weakness.NPO
Q2 2024 - Q3 2024 sales and margins rose, but guidance was cut on semiconductor and OEM weakness.NPO
Q3 2024 - Adjusted EBITDA rose 7.1% in 2024; 2025 outlook remains positive despite market headwinds.NPO
Q4 2024